Clinical Profile and Course of Patients with Acute Respiratory Distress Syndrome due to COVID-19 in a Middle-Income Region in Mexico

1. Gordo-Vidal F, Enciso-Calderón V. Síndrome de distrés respiratorio agudo, ventilación mecánica y función ventricular derecha [Acute respiratory distress syndrome, mechanical ventilation and right ventricular function]. Med Intensiva 2012;36(2):138–42. Gordo-VidalF Enciso-CalderónV Síndrome de distrés respiratorio agudo, ventilación mecánica y función ventricular derecha [Acute respiratory distress syndrome, mechanical ventilation and right ventricular function] Med Intensiva 2012 36 2 138 42 Search in Google Scholar

2. Gorman EA, O’Kane CM, McAuley DF. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management. Lancet. (2022) 1; 400(10358):1157–70. GormanEA O’KaneCM McAuleyDF Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management Lancet 2022 1 400 10358 1157 70 Search in Google Scholar

3. Calfee CS, Delucchi KL, Sinha P, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomized controlled trial. Lancet Respiratory Medicine. 2018;6(9): 691–8. CalfeeCS DelucchiKL SinhaP Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomized controlled trial Lancet Respiratory Medicine 2018 6 9 691 8 Search in Google Scholar

4. WeVent. Protocolo respiratorio de pacientes con SARS-CoV-2 (COVID-19). Disponible en: https://www.formacionsanitaria.eu/index.php/es/wevent?fbclid=IwAR3-v_7JY2K9IRInVOEIMy1uC5Lb28fML72Dsnrlt_eFHCRDHt1s5jZEmNY. WeVent Protocolo respiratorio de pacientes con SARS-CoV-2 (COVID-19) Disponible en: https://www.formacionsanitaria.eu/index.php/es/wevent?fbclid=IwAR3-v_7JY2K9IRInVOEIMy1uC5Lb28fML72Dsnrlt_eFHCRDHt1s5jZEmNY. Search in Google Scholar

5. Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatment for different phenotypes?. Intensive care medicine. 2020;46: 1099–1102. GattinoniL ChiumelloD CaironiP COVID-19 pneumonia: different respiratory treatment for different phenotypes? Intensive care medicine 2020 46 1099 1102 Search in Google Scholar

6. Bos L, Paulus F, Vlaar A, et al. Subphenotyping ARDS in COVID-19 Patients: Consequences for Ventilator Management. Annals ATS. (2020). BosL PaulusF VlaarA Subphenotyping ARDS in COVID-19 Patients: Consequences for Ventilator Management Annals ATS 2020 Search in Google Scholar

7. Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Critical Care 2020;24(1):1–3. GattinoniL ChiumelloD RossiS COVID-19 pneumonia: ARDS or not? Critical Care 2020 24 1 1 3 Search in Google Scholar

8. Rello J, Storti E, Belliato M, et al. Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers. European Respiratory Journal. 2020;55(5): 1–4. RelloJ StortiE BelliatoM Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers European Respiratory Journal 2020 55 5 1 4 Search in Google Scholar

9. Robba C, Battaglini D, Ball L, et al. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19, Respiratory Physiology and neurobiology. 2020;279:103455 RobbaC BattagliniD BallL Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 Respiratory Physiology and neurobiology 2020 279 103455 Search in Google Scholar

10. Bellani G, Laffey JG, Pham T, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315(8):788–800. BellaniG LaffeyJG PhamT Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries JAMA 2016 315 8 788 800 Search in Google Scholar

11. Sinha P, Calfee CS, Cherian S, et al. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study. Lancet Respiratory Medicine. 2020;8(12):1209–18. SinhaP CalfeeCS CherianS Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study Lancet Respiratory Medicine 2020 8 12 1209 18 Search in Google Scholar

12. Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. COVID-19 Spanish ICU Network. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med 2020;46:2200–11. FerrandoC Suarez-SipmannF Mellado-ArtigasR COVID-19 Spanish ICU Network Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS Intensive Care Med 2020 46 2200 11 Search in Google Scholar

13. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 2021;47:60–73 COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study Intensive Care Med 2021 47 60 73 Search in Google Scholar

14. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA 2020;180(7):934–43. WuC ChenX CaiY Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China JAMA 2020 180 7 934 43 Search in Google Scholar

15. Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382(18):1708–1720. GuanWJ NiZY HuY China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China N Engl J Med 2020 382 18 1708 1720 Search in Google Scholar

16. Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020;395(10223):497–506. HuangC WangY LiX RenL Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China The Lancet 2020 395 10223 497 506 Search in Google Scholar

17. Chen T, Wu D, Chen H, Yan W, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091 ChenT WuD ChenH YanW Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study BMJ 2020 368 m1091 Search in Google Scholar

18. Reyes LF, Bastidas A, Narváez PO, et al. Clinical characteristics, systemic complications, and in-hospital outcomes for patients with COVID-19 in Latin America. LIVEN-Covid-19 study: A prospective, multicenter, multinational, cohort study. PloS One. 2022;17(3):e0265529. ReyesLF BastidasA NarváezPO Clinical characteristics, systemic complications, and in-hospital outcomes for patients with COVID-19 in Latin America. LIVEN-Covid-19 study: A prospective, multicenter, multinational, cohort study PloS One 2022 17 3 e0265529 Search in Google Scholar

19. Chand S, Kapoor S, Orsi D, et al. COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center. J Intensive Care Med 2020; 35(10):963–970. ChandS KapoorS OrsiD COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center J Intensive Care Med 2020 35 10 963 970 Search in Google Scholar

20. Friedman AN, Guirguis J, Kapoor R, et al. Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US. Obesity (Silver Spring). 2021; 29(10):1719–30. FriedmanAN GuirguisJ KapoorR Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US Obesity (Silver Spring) 2021 29 10 1719 30 Search in Google Scholar

21. Olivas-Martínez A, Cárdenas-Fragoso JL, Jiménez JV, et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PloS one 2021;16(2):e0245772 Olivas-MartínezA Cárdenas-FragosoJL JiménezJV In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation PloS one 2021 16 2 e0245772 Search in Google Scholar

22. Cueto-Manzano AM, Espinel-Bermúdez MC, Hernández-González SO, et al. Risk factors for mortality of adult patients with COVID-19 hospitalised in an emerging country: a cohort study. BMJ 2021;11(7):e050321. Cueto-ManzanoAM Espinel-BermúdezMC Hernández-GonzálezSO Risk factors for mortality of adult patients with COVID-19 hospitalised in an emerging country: a cohort study BMJ 2021 11 7 e050321 Search in Google Scholar

23. Ramírez P, Gordón M, Martín-Cerezuela M, et al. Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain. Medicina Intensiva 2021;45(1):27–34. RamírezP GordónM Martín-CerezuelaM Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain Medicina Intensiva 2021 45 1 27 34 Search in Google Scholar

24] Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021;12(7):1026–1041. Viurcos-SanabriaR EscobedoG Immunometabolic bases of type 2 diabetes in the severity of COVID-19 World J Diabetes 2021 12 7 1026 1041 Search in Google Scholar

25. Ejaz H, Alsrhani A, Zafar A, at el. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833–39. EjazH AlsrhaniA ZafarA COVID-19 and comorbidities: Deleterious impact on infected patients J Infect Public Health 2020 13 12 1833 39 Search in Google Scholar

26. COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. The Lancet; 2022. 399(10334):1513–36. COVID-19 Excess Mortality Collaborators Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 The Lancet 2022 399 10334 1513 36 Search in Google Scholar

27. Singh H, Dahiya N, Yadav M, et al. Emergence of SARS-CoV-2 New Variants and Their Clinical Significance. Canadian Journal Infectious Diseases Medical Microbiology. 2022;2022:7336309. SinghH DahiyaN YadavM Emergence of SARS-CoV-2 New Variants and Their Clinical Significance Canadian Journal Infectious Diseases Medical Microbiology 2022 2022 7336309 Search in Google Scholar

28. Saavedra-López MA, Calle-Ramirez XM, Hernández RM. Latin American authorship in scientific production on COVID-19. Rev Esp Enferm Dig 2021;113(2):147. Saavedra-LópezMA Calle-RamirezXM HernándezRM Latin American authorship in scientific production on COVID-19 Rev Esp Enferm Dig 2021 113 2 147 Search in Google Scholar

29. Naffeti B, Bourdin S, Ben Aribi W, et al. Spatio-temporal evolution of the COVID-19 across African countries. Frontiers in Public Health 2022;10:1039925. NaffetiB BourdinS Ben AribiW Spatio-temporal evolution of the COVID-19 across African countries Frontiers in Public Health 2022 10 1039925 Search in Google Scholar

30. Islas Cerón RG, Valencia Ortíz AI, Bustos Vázquez E, et al. Asociación entre calidad de atención y el nivel de saturación del servicio de urgencias de un hospital de Hidalgo, México. Journal of Negative and No Positive Results 2020;5(10):1163–78. Islas CerónRG Valencia OrtízAI Bustos VázquezE Asociación entre calidad de atención y el nivel de saturación del servicio de urgencias de un hospital de Hidalgo, México Journal of Negative and No Positive Results 2020 5 10 1163 78 Search in Google Scholar

31. Khan M, Adil SF, Alkhathlan HZ, et al. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules 2020;26(1):39. KhanM AdilSF AlkhathlanHZ COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far Molecules 2020 26 1 39 Search in Google Scholar

32. IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp IBM Corp Released 2020. IBM SPSS Statistics for Windows, Version 27.0 Armonk, NY IBM Corp Search in Google Scholar

33. Dahiru T. P - value, a true test of statistical significance? A cautionary note. Annls of Ibadan postgraduate medicina. 2008;6(1):21–6. DahiruT P - value, a true test of statistical significance? A cautionary note Annls of Ibadan postgraduate medicina 2008 6 1 21 6 Search in Google Scholar

34. Campos-Nonato I, Galván-Valencia Ó, Hernández-Barrera L, et al. Prevalencia de obesidad y factores de riesgo asociados en adultos mexicanos: resultados de la Ensanut 2022. Salud Publica Mex. 2023;65:238–47. Campos-NonatoI Galván-ValenciaÓ Hernández-BarreraL Prevalencia de obesidad y factores de riesgo asociados en adultos mexicanos: resultados de la Ensanut 2022 Salud Publica Mex 2023 65 238 47 Search in Google Scholar

35. Bórquez-López YF, Monares-Zepeda E, Franco-Granillo J, et al. Síndrome de dificultad respiratoria vs síndrome de dificultad respiratoria por COVID-19: las diferencias que realmente importan. Medicina crítica (Colegio Mexicano de Medicina Crítica). 2021;35(4):176–81. Bórquez-LópezYF Monares-ZepedaE Franco-GranilloJ Síndrome de dificultad respiratoria vs síndrome de dificultad respiratoria por COVID-19: las diferencias que realmente importan Medicina crítica (Colegio Mexicano de Medicina Crítica) 2021 35 4 176 81 Search in Google Scholar

36. Torrelles JB, Restrepo BI, Bai Y, Ross C, Schlesinger LS, Turner J. (2022). The Impact of Aging on the Lung Alveolar Environment, Predetermining Susceptibility to Respiratory Infections. Front. Aging. 3:818700. TorrellesJB RestrepoBI BaiY RossC SchlesingerLS TurnerJ 2022 The Impact of Aging on the Lung Alveolar Environment, Predetermining Susceptibility to Respiratory Infections Front. Aging. 3 818700 Search in Google Scholar

37. López-Simarro F, Redondo Margüello E, Mediavilla Bravo JJ, et al. Prevención y tratamiento de la enfermedad infecciosa en personas con diabetes. Medicina de familia SEMERGEN 2019;45(2):117–27. López-SimarroF Redondo MargüelloE Mediavilla BravoJJ Prevención y tratamiento de la enfermedad infecciosa en personas con diabetes Medicina de familia SEMERGEN 2019 45 2 117 27 Search in Google Scholar

38. Ejaz H, Alsrhani A, Zafar A, et al. Deleterious impact on infected patients. J Infect Public Health 2020;13(12):1833–39. EjazH AlsrhaniA ZafarA Deleterious impact on infected patients J Infect Public Health 2020 13 12 1833 39 Search in Google Scholar

39. Pérez-Abeledo M, Sanz Moreno JC. Variantes de SARS-CoV-2, una historia todavía inacabada [SARS-CoV-2 variants, a still unfinished story]. Vacunas 2021;22(3):173–79 Pérez-AbeledoM Sanz MorenoJC Variantes de SARS-CoV-2, una historia todavía inacabada [SARS-CoV-2 variants, a still unfinished story] Vacunas 2021 22 3 173 79 Search in Google Scholar

40. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA; 2020;323(20):2052–59. RichardsonS HirschJS NarasimhanM Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area JAMA 2020 323 20 2052 59 Search in Google Scholar

41] Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respiratory Medicine 2020;8(5):475–81. YangX YuY XuJ Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respiratory Medicine 2020 8 5 475 81 Search in Google Scholar

42] Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323(11):1061–69. WangD HuB HuC Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China JAMA 2020 323 11 1061 69 Search in Google Scholar

43. Lim ZJ, Subramaniam A, Ponnapa Reddy M, et al. Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis. American journal of respiratory and critical care medicine 2021;203(1):54–66. LimZJ SubramaniamA Ponnapa ReddyM Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis American journal of respiratory and critical care medicine 2021 203 1 54 66 Search in Google Scholar

44. Papazian L, Aubron C, Brochard L, et al. Formal guidelines: management of acute respiratory distress syndrome. Annals of Intensive Care 2019;9(1):69. PapazianL AubronC BrochardL Formal guidelines: management of acute respiratory distress syndrome Annals of Intensive Care 2019 9 1 69 Search in Google Scholar

45. Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Medicine 2020; 46(12):2200–11. FerrandoC Suarez-SipmannF Mellado-ArtigasR Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS Intensive Care Medicine 2020 46 12 2200 11 Search in Google Scholar

46] Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. New England Journal Medicine 1998; 338(6):347–54. AmatoMB BarbasCS MedeirosDM Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome New England Journal Medicine 1998 338 6 347 54 Search in Google Scholar

47. Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. New England Journal Medicine 2015; 372(8):747–55. AmatoMB MeadeMO SlutskyAS Driving pressure and survival in the acute respiratory distress syndrome New England Journal Medicine 2015 372 8 747 55 Search in Google Scholar

48. Namendys-Silva SA. ECMO for ARDS due to COVID-19. Heart Lung. The Journal of Cardiopulmonary and Acute Care 2020;49(4):348–49. Namendys-SilvaSA ECMO for ARDS due to COVID-19. Heart Lung The Journal of Cardiopulmonary and Acute Care 2020 49 4 348 49 Search in Google Scholar

49. Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19 associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respiratory Medicine 2020;8(12):1201–08. GrasselliG TonettiT ProttiA Pathophysiology of COVID-19 associated acute respiratory distress syndrome: a multicentre prospective observational study Lancet Respiratory Medicine 2020 8 12 1201 08 Search in Google Scholar